New research suggests an association between gestational diabetes history and mortality over 30 years, regardless of whether it manifests into type 2 diabetes.
Individuals with a history of gestational diabetes have a slightly elevated risk of subsequent mortality over a 30-year period compared with individuals without a history, a new study published in JAMA Internal Medicine suggests.
This finding is based on a cohort study of more than 91,000 participants of the Nurses’ Health Study II, with a 30-year follow-up between 1989 and 2019.
The study included US female nurses aged 25 to 42 years with a mean (SD) aged of 34.9 (4.7) years. All women in the study reported at least 1 pregnancy lasting at least 6 months during adulthood, and the mean body mass index (BMI) at baseline was 24.1 (4.7). Across more than 2.6 million person-years, there were 3937 recorded deaths, including 255 caused by cardiovascular disease (CVD) and 1397 caused by cancer. All findings had a CI of 95%.
The study investigators found that individuals who reported a history of gestational diabetes were 1.28 (1.13-1.44) times more likely to experience mortality over the next 30 years, with a higher crude mortality rate of 1.74 per 1000 person-years compared with 1.49 for those without a history of gestational diabetes. After further adjusting for potential confounders and lifestyle factors during women’s reproductive years, the risk did not drastically change (HR, 1.25; 1.11-1.41).
Interestingly, this association persisted regardless of whether women developed type 2 diabetes (T2D) following their pregnancy. Less-healthy lifestyle factors also contributed to this association, including:
Associations were also stronger for women who:
Additionally, cause-specific mortality analyses revealed that gestational diabetes was directly associated with risk of CVD-associated mortality (HR, 1.59; 1.03-2.47). Meanwhile, gestational diabetes was inversely associated with cancer mortality (HR, 0.76; 0.59-0.98), but this was only evident among women who later developed T2D.
“Results from the cause-specific proportional hazards models suggest that this inverse association is unlikely to be associated with the competing risk of mortality from other causes,” the investigators said. “Instead, it could be partly explained by early detection, management of medical conditions, and lifestyle interventions (eg, BMI reduction or maintenance, healthy diet, and physical activity) that are often recommended to patients with T2D.”
The study has several limitations that are important to note. First, self-reported gestational diabetes could potentially introduce exposure misclassification, although it's considered highly accurate in this study population. Second, the predominance of non-Hispanic White participants as well as the limited number of non-CVD or non-cancer deaths may limit the generalizability of the findings. Additionally, the study lacked data on prediabetes, gestational diabetes onset age, and disease severity, and the study’s observational design prevented the investigators from making any causal associations.
“The findings emphasize the importance for health care professionals to consider gestational diabetes as a critical factor when evaluating the later-life mortality risk of their patients,” the investigators concluded.
Reference
Wang YX, Mitsunami M, Manson JE, et al. Association of gestational diabetes with subsequent long-term risk of mortality. JAMA Intern Med. Published online September 11, 2023. doi:10.1001/jamainternmed.2023.4401
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen